GGrantIndex
← Leaderboards

Tobias Gerhard

Rutgers, The State Univ Of N.J.

$6,199,924
Attributed
$6,199,924
Total exposure
4
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.2M · FY201425
$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,160,624 · 3
AHRQ$39,300 · 1

By mechanism

R01$5,734,374 · 2
R21$426,250 · 1
P30$39,300 · 1

Top collaborators

No co-investigators on record.

Most similar at Rutgers, The State Univ Of N.J.

Same institution · by research overlap

Others in their field

Top investigators on “Pharmaceutical Preparations

Research focus

Pharmaceutical PreparationsCharacteristicsDesignAffectElderlyMethodologyInnovationEvidence BaseResearch DesignPublic HealthTreatment GuidelinesDrug UsageClinical MedicineMedicareData ResourcePatient-Focused OutcomesClinically RelevantBaseChronicStructureCardiovascular DiseasesIndexingNon-Insulin-Dependent Diabetes MellitusDose

Grant awards (14)

Research and Data Analysis Core$19,650
P30 · FY2025 · HS · contact PI
A Novel Approach to Examine Within-Class Therapeutic Exchangeability of Medications$518,903
R01 · FY2024 · AG · contact PI
Research and Data Analysis Core$19,650
P30 · FY2024 · HS · contact PI
A Novel Approach to Examine Within-Class Therapeutic Exchangeability of Medications$580,634
R01 · FY2023 · AG · contact PI
Strengthening the Evidence-Base for Drug-Disease Interactions in Older Adults$470,045
R01 · FY2023 · AG · contact PI
A Novel Approach to Examine Within-Class Therapeutic Exchangeability of Medications$607,991
R01 · FY2022 · AG · contact PI
Strengthening the Evidence-Base for Drug-Disease Interactions in Older Adults$573,578
R01 · FY2022 · AG · contact PI
A Novel Approach to Examine Within-Class Therapeutic Exchangeability of Medications$606,674
R01 · FY2021 · AG · contact PI
Strengthening the Evidence-Base for Drug-Disease Interactions in Older Adults$562,383
R01 · FY2021 · AG · contact PI
A Novel Approach to Examine Within-Class Therapeutic Exchangeability of Medications$566,464
R01 · FY2020 · AG · contact PI
Strengthening the Evidence-Base for Drug-Disease Interactions in Older Adults$561,369
R01 · FY2020 · AG · contact PI
Strengthening the Evidence-Base for Drug-Disease Interactions in Older Adults$686,333
R01 · FY2019 · AG · contact PI
Safety of Second Generation Antipsychotics for Adult Depression$193,750
R21 · FY2015 · MH · contact PI
Safety of Second Generation Antipsychotics for Adult Depression$232,500
R21 · FY2014 · MH · contact PI